Since two pioneering reports introduced the impact of ADAR1 in gastric cancer progression [14,15], others have reported targets including Antizyme Inhibitor 1 (AZIN1) [16], mTOR/p70S6K pathway [17], and Phosphatase And Actin Regulator 4 (PHACTR4) [18]. The gene discussed is PHACTR4; the disease is gastric cancer.